Related Experiment Video
Updated: Mar 12, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.6K
Mechanisms of Aberrant PKA Activation by Cα Subunit Mutations
D Calebiro1, K Bathon1, I Weigand2
1Institute of Pharmacology and Toxicology, University Hospital, University of Würzburg, Würzburg, Germany.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|November 5, 2016
Summary
Somatic mutations in PRKACA cause constitutive activation of protein kinase A (PKA), leading to adrenal Cushing's syndrome. These genetic alterations disrupt the interaction between PKA subunits, resulting in uncontrolled hormone production.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Adrenocortical adenomas causing Cushing's syndrome are frequently linked to somatic mutations.
- The gene PRKACA, encoding the catalytic subunit of protein kinase A (PKA), is the most commonly altered gene in these tumors.
Purpose of the Study:
- To review recent findings on PRKACA mutations in cortisol-secreting adrenocortical adenomas.
- To elucidate the mechanisms by which PRKACA mutations lead to PKA activation and adrenal Cushing's syndrome.
Main Methods:
- Review of functional studies on specific PRKACA mutations (L206R, 199_200insW).
- Analysis of mutation effects on PKA subunit interactions and activity.
- Examination of cyclic AMP (cAMP) regulation disruption.
Main Results:
- Mutations cluster at the interface of PKA's catalytic (C) and regulatory (R) subunits.
- Identified mutations result in constitutively active PKA.
- Mutations interfere with R subunit binding, preventing cAMP-mediated regulation.
Conclusions:
- PRKACA mutations are a key driver of PKA activation in adrenal Cushing's syndrome.
- Understanding these mechanisms is crucial for comprehending tumorigenesis and developing targeted therapies.
Related Concept Videos
01:07MAPK Signaling Cascades
9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
01:22Amplifying Signals via Enzymatic Cascade
19.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.0K
01:25cAMP-dependent Protein Kinase Pathways
8.9K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.9K
01:16Calmodulin-dependent Signaling
6.9K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
6.9K
02:54Protein Kinases and Phosphatases
15.4K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.4K
01:22PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K